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The production of IL-1β during the infection with Mycobacterium tuberculosis (Mtb)
is important for successful host immune defense. In macrophages and dendritic
cells the host cell inflammasome is crucial for generation of secreted IL-1β in
response to Mtb infections. In these cell types Mtb infection only activates the
NLRP3-inflammasome. New reports demonstrate that nitric oxide has an important
function in the negative regulation of the NLRP3-inflammasome to reduce tissue damage
during Mtb infections. The type I interferon, IFN-β, is induced after Mtb infections and
can also suppress NLRP3-inflammasome activation. In contrast, IFN-β increases activity
of the AIM2-inflammasome after infection with intracellular pathogens such as Francisella
tularensis and Listeria monocytogenes. Recent results demonstrate that non-tuberculous
mycobacteria but not virulent Mtb induce the AIM2-inflammasome in an IFN-β dependent
matter. Indeed, Mtb inhibits AIM2-inflammasome activation via its ESX-1 secretion
system. This novel immune evasion mechanism may help Mtb to allow the induction
of low levels of IFN-β to suppress the NLRP3-inflammasome without activating the
AIM2-inflammasome.
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INTRODUCTION
IL-1β is important for host immune defense against Mtb, since
several studies demonstrated that IL-1β and IL-1-receptor knock-
out mice are more susceptible to Mtb infections (Mayer-Barber
et al., 2010, 2011; Mcelvania Tekippe et al., 2010). According
to some studies IL-18 has no or only a minor role in host
defense against Mtb but more recently one report showed an
increased susceptibility of IL-18 but not IL-18R knockout mice
[for review (Cooper et al., 2011)]. In macrophages and dendritic
cells the production of mature IL-1β and IL-18 is dependent on
activation of the inflammasome (Schroder and Tschopp, 2010).
Within the inflammasome complex, the cleavage of pro-IL-1β and
pro-IL-18 is mostly performed by caspase-1 with help of caspase-
11 (Rathinam et al., 2012). Nevertheless, there is a fraction of
cytokine maturation that is not performed by the caspase-1/-
11 pathway (Mayer-Barber et al., 2010; Mcelvania Tekippe et al.,
2010; Abdalla et al., 2012) butmost likely by caspase-8 (Gringhuis
et al., 2012). The NLR (nucleotide-binding and oligomerization
domain, leucine-rich-repeat-containing) proteins such as NLRP3
and NLRC4 are one family of cytosolic receptors, which upon
ligand binding mediate inflammasome activation. In the case of
Mtb, most studies using ex vivo analysis of macrophages and den-
dritic cells identify NLRP3 as the sole NLR capable of inducing
inflammasome activation (Carlsson et al., 2010; Mayer-Barber
et al., 2010; Mcelvania Tekippe et al., 2010; Mishra et al., 2010;
Wong and Jacobs, 2011; Abdalla et al., 2012; Dorhoi et al., 2012).
Absent in Melanoma 2 (AIM2) is the best studied member of the
HIN-200 family of DNA binding proteins, which is involved in
the surveillance of the cytosol for double-strandedDNA (dsDNA)
(Burckstummer et al., 2009; Fernandes-Alnemri et al., 2009;
Hornung et al., 2009). Despite an apparent failure of Mtb to
activate the AIM2-inflammasome ex vivo, Aim2−/− mice are
more susceptible to Mtb infections demonstrating a role for the
AIM2 inflammasome in vivo and/or a putative inflammasome-
independent function of AIM2 in host defense (Saiga et al., 2012).
Here we will review and discuss the recent literature on the
molecular mechanisms of the interaction of Mtb with NLRP3
and AIM2 inflammasomes and their connection with type I IFN
signaling.
INTERACTION OF MTBWITH HOST CELL
NLRP3-INFLAMMASOME
Infection of macrophages or dendritic cells deficient in NLRP3
with Mtb does not induce secretion of IL-1β or IL-18 (Carlsson
et al., 2010; Mayer-Barber et al., 2010; Mcelvania Tekippe et al.,
2010; Mishra et al., 2010; Wong and Jacobs, 2011; Abdalla et al.,
2012; Dorhoi et al., 2012). The dogma for NLRs has been that
they bind to a pathogen and/or danger associated molecular
pattern (P/DAMP) in the host cell cytosol, which triggers their
activation and subsequent formation of active inflammasomes.
Nevertheless, the nature of such a ligand for NLRP3 has remained
elusive. Recent publications suggest that there may not be a
P/DAMP directly binding to NLRP3. Instead, cytosolic viral and
bacterial RNA is sensed by DHX33, which then binds to and acti-
vates NLRP3 (Mitoma et al., 2013). Bacterial toxins, phagocytosis
and other cellular insults result in potassium depletion in the
cytosol, which serves as an activator of NLRP3 (Munoz-Planillo
et al., 2013). Consistently, it was shown that potassium depletion
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is required for Mtb and non-tuberculous mycobacteria (NTM)-
mediated inflammasome activation in macrophages (Kurenuma
et al., 2009; Chen et al., 2012; Dorhoi et al., 2012; Lee et al.,
2012, 2013). The protein tyrosine kinase Syk has been impli-
cated in Mtb-mediated inflammasome activation (Wong and
Jacobs, 2011), which is consistent with its previously identi-
fied role in activating the NLRP3-inflammasome after infection
with the fungal pathogen Candida albicans (Gross et al., 2009).
Another positive regulator is the thioredoxin-interacting pro-
tein that is activated by the loss of binding to thioredoxin after
increase in cytosolic reactive oxygen species (ROS) and which
subsequently binds to NLRP3 to activate it (Zhou et al., 2010).
Nevertheless, this pathway is unlikely to be involved in Mtb-
mediated NLRP3-inflammasome activation because inhibitors of
ROS had no effect (Wong and Jacobs, 2011; Dorhoi et al., 2012).
ROS-dependent and -independent pathways seem to converge at
the mitochondrial membrane where the generation of the lipid
cardiolipin can stimulate the NLRP3-inflammasome by binding
to NLRP3 (Iyer et al., 2013). Finally, the guanylate binding pro-
tein 5 promotes NLRP3-inflammasome assembly and activation
in response to bacterial infections as shown for Listeria monocy-
togenes and Salmonella typhimurium (Shenoy et al., 2012) but its
role during Mtb infection has not been analyzed.
During the course of Mtb infections, the increase of IFN-
γ in the lungs results in higher levels of nitric oxide (NO).
Interestingly, NO has the capacity to negatively regulate the
NLRP3-inflammasome and hence reduce IL-1β production
(Mishra et al., 2013). The direct S-nitrosylation of NLRP3
accounts for the inhibitory effect of NO (Hernandez-Cuellar
et al., 2012; Mishra et al., 2013). This aspect of NO activity
is important to suppress tissue damage produced by continu-
ous activation of innate immunity (Hernandez-Cuellar et al.,
2012; Mishra et al., 2013). Another negative regulator of the
NLRP3-inflammasome are omega-3 fatty acids which may pre-
vent excessive inflammation and metabolic disorder (Yan et al.,
2013). Furthermore, the LRRFIP2 binds to NLRP3 and also inter-
acts with Flightless-1 to stimulate its binding to and subsequent
inhibition of caspase-1 (Jin et al., 2013). The roles of these NLRP3
inflammasome regulatory pathways during Mtb infections have
not been investigated.
INTERACTION OF MTBWITH HOST CELL
AIM2-INFLAMMASOME
Intracellular bacterial pathogens such as F. tularensis and L. mono-
cytogenes have been shown to induce the AIM2-inflammasome
(Fernandes-Alnemri et al., 2010; Jones et al., 2010; Sauer et al.,
2010; Tsuchiya et al., 2010). Interestingly, bacterial mutants of
F. tularensis and L. monocytogenes in virulence factors that are
important for bacterial access to host cell cytosol are deficient in
activation of the inflammasome (Henry et al., 2007; Sauer et al.,
2010). It is believed that during access to host cell cytosol some
bacterial dsDNA also enters the cytosol where it will be recognized
by AIM2 (Fernandes-Alnemri et al., 2010; Jones et al., 2010; Sauer
et al., 2010). Indeed, AIM2 binds indiscriminately to cytosolic
double-stranded DNA which could be of artificial (poly dA:dT),
microbial or mammalian origin (Muruve et al., 2008; Rathinam
et al., 2010).
The type VII secretion system (ESX-1) of Mtb mediates
translocation of Mtb extracellular DNA (eDNA) into the host
cell cytosol where it can activate the DNA sensor IFI16/IFI204
which results in the initiation of a signaling cascade that ulti-
mately leads to the production of IFN-β (Figure 1) (Stanley
et al., 2007; Manzanillo et al., 2012). In the light of the indis-
criminate binding of AIM2 to dsDNA it is surprising that the
cytosolic Mtb eDNA does not induce activation of the AIM2
inflammasome. A clue on how to resolve this conundrum was
offered by our recent finding that Mtb does not induce AIM2-
inflammasome activation but other NTM, such as M. smegmatis
(Msme), do (Shah et al., 2013). Msme has a functional ESX-
1 system that is important for conjugal DNA transfer (Flint
et al., 2004). Similar to the L. monocytogenes listeriolysin O
mutant, the ESX-1 deficient Msme mutant showed a signifi-
cant reduction in AIM2-inflammasome activation. Furthermore,
Mtb could inhibit AIM2-inflammasome activation induced by
infection with either Msme or the transfection of dsDNA (Shah
et al., 2013). This inhibition by Mtb was dependent upon the
presence of a functional ESX-1 system, since an ESX-1 defi-
cient Mtb mutant failed to inhibit AIM2 activation (Shah et al.,
2013). This suggests that the same secretion system that is respon-
sible for introducing AIM2 ligands into the host cell cytosol
may also transfer an effector that inhibits the AIM2 activation
(Figure 1). The ESX-1 secretion system is also important for
the escape of a fraction of intracellular Mtb from the phago-
some into the cytosol (Van Der Wel et al., 2007; Houben et al.,
2012; Simeone et al., 2012). The entry of Mtb into the cytosol
FIGURE 1 | Overview of Mtb host cell inflammasome interactions. Mtb
secretes dsDNA, which induces IFN-β production but also expresses TLR-2
agonists that inhibit. Nevertheless, overall there is an increase in IFN-β,
which limits pro-IL-1β and pro-IL-18 transcription and has opposing effects
on inflammasome activation. IFN-β inhibits the NLRP3-inflammasome but
stimulates the AIM2-inflammasome. To limit AIM2-mediated IL-1β
production, Mtb secretes putative effector(s) via its ESX-1 system, as
indicated by “?.” They either directly or indirectly inhibit the
AIM2-inflammasome resulting in diminished caspase-1 activation and
subsequent reduction in IL-1β and IL-18 production. Green color denotes
connections that are beneficial to the host; those in red are beneficial to the
pathogen and in black those where this is unclear.
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could be another pathway for AIM2-inflammasome activation as
it has been described for other bacteria that escape the phago-
some (Brodsky and Monack, 2009). Nevertheless, Mtb escapes
the phagosome at a very late stage (only after several days) dur-
ing the infection (Houben et al., 2012; Simeone et al., 2012).
In contrast, IL-1β production is usually analyzed within the
first 24 h of infection and hence the current data in the liter-
ature on Mtb-inflammasome activation does not take the Mtb
entry in the host cell cytosol into account. Analysis of these
events during the late phase of the infection cycle would be very
informative and may reveal Mtb-mediated AIM2-inflammasome
activation.
The importance and probably also the limits of Mtb-mediated
AIM2 inflammasome inhibition are highlighted by a study that
demonstrates the increased susceptibility of Aim2−/− mice and
decreased levels of IL-1β and IL-18 in the lungs of these mice
after Mtb infection (Saiga et al., 2012). The ex vivo analysis of
macrophage infection in this study, demonstrating reduced IL-
1β secretion in Aim2−/− cells is in contradiction to many reports
showing the sole dependence of BMDMs on NLRP3 for IL-1β
production after Mtb infection. This may be due to the nature of
macrophages used because in Saiga et al. thioglycollate-induced
peritoneal macrophages were used as opposed to BMDMs in
(Mayer-Barber et al., 2010; Mcelvania Tekippe et al., 2010;
Mishra et al., 2010; Wong and Jacobs, 2011; Abdalla et al.,
2012; Dorhoi et al., 2012). A more recent report that vir-
ulent M. bovis induce AIM2-inflammasome activation in a
murine macrophage cell line further underscores the potential
for AIM2-inflammasome in host defense against mycobacteria
(Yang et al., 2013).
THE ROLE OF IFN-β IN MTB-INFLAMMASOME
INTERACTIONS
The significance of type I IFN signaling for activation of
AIM2-inflammasome responses was first reported for F. tularen-
sis and L. monocytogenes infected macrophages (Henry et al.,
2007). Some reports demonstrate that the IFN-β acts at the
level of increased transcription and translation of Aim2 in order
to increase AIM2-inflammasome activity (Jones et al., 2010;
Tsuchiya et al., 2010). A conflicting report failed to detect changes
in protein levels of AIM2 after infection with F. tularensis but con-
firmed the importance of this cytokine for AIM2-inflammasome
activation (Fernandes-Alnemri et al., 2010). We reported that
NTM induce secretion of up to 20fold higher levels of IFN-βwhen
compared to Mtb infection (Shah et al., 2013). Furthermore,
experiments using IFN-β neutralizing antibodies and Ifnar1−/−
deficient cells demonstrated a stimulatory role of IFN-β in the
context of infections with NTMs (Shah et al., 2013). This is very
comparable to the effect of IFN-β during F. tularensis or L. mono-
cytogenes mediated inflammasome activation (Henry et al., 2007;
Tsuchiya et al., 2010). Consequently, one could argue that min-
imizing IFN-β production will optimize the virulence of Mtb
since there was an inverse correlation between IFN-β produc-
tion and virulence. Nevertheless, the current paradigm is that an
increase in type I IFN production leads to increased Mtb viru-
lence (Manca et al., 2001, 2005; Stanley et al., 2007; Berry et al.,
2010; Mayer-Barber et al., 2011; Manzanillo et al., 2012).
During the course of Mtb ex vivo infections of macrophages
and dendritic cells no AIM2-inflammasome activation is
detected. In this context, IFN-β has the opposite effect and
suppresses activation of the NLRP3 inflammasome (Figure 1)
(Mayer-Barber et al., 2011; Novikov et al., 2011). The mecha-
nism of this inhibition involves the IFN-β mediated induction
of IL-10 which suppresses IL-1β production (Mayer-Barber et al.,
2011; Novikov et al., 2011). How then doesMtb inhibit the AIM2-
inflammasome in the presence of IFN-β? The pre-infection of
cells with Mtb inhibited IFN-β production induced by Msme
in an ESX-1 dependent manner (Shah et al., 2013). This is
in agreement with a previous report demonstrating that Mtb-
induced TLR-2 signaling leads to depletion of IRAK1, which is
required for TLR7/9-induced IFN-β production (Liu et al., 2012).
These two reports show that Mtb is able to inhibit the produc-
tion of IFN-β (Liu et al., 2012; Shah et al., 2013). Nevertheless,
we demonstrated that the inhibition of IFN-β production is
only a minor cause of the Mtb-mediated AIM2-inflammasome
inhibition, since adding extracellular IFN-β did not completely
overcome the inhibition (Shah et al., 2013). In addition, we
showed that Mtb is capable of inhibiting autocrine IFN-β sig-
naling (Shah et al., 2013). This observation is consistent with
the previous report that Mtb inhibits IFN-α signaling, by reduc-
ing STAT1 phosphorylation and homodimer formation, since
IFN-β and IFN-α signal through the same receptor (Prabhakar
et al., 2003). This inhibition of IFN-β signaling may be linked
to the inhibition of the AIM2 inflammasome but via a path-
way that does not involve transcription or translational regu-
lation of Aim2, since those were not affected by Mtb infection
(Shah et al., 2013). Clearly, further investigation is needed to
determine the molecular mechanism of Mtb mediated AIM2-
inflammasome inhibition and its importance for bacterial vir-
ulence. In addition, the inhibition of IFN-β signaling could
have the added benefit of reducing the production of IL-1β via
the NLRP3 inflammasome. One example of a mechanism for
such an inhibition could be the effect on caspase-11 activa-
tion, which is part of the IFNAR1 signaling pathway engaged by
IFN-β. The activated caspase-11 synergizes with caspase-1 dur-
ing NLRP3-inflammasome mediated maturation of pro-IL-1β
(Rathinam et al., 2012). In conclusion, Mtb may have adapted to
exploiting the pathogen-beneficial functions of IFN-β to exacer-
bate disease and inhibit the NLRP3-inflammasome by inhibiting
potentially detrimental effects of IFN-β, which are the activa-
tion of the AIM2-inflammasome and autocrine IFN-β signaling
(Figure 1).
Another point accentuated by our study (Shah et al., 2013) is
that approaches comparing virulent Mtb with a broader spec-
trum of NTMs may help pointing toward inhibitory capacities
of Mtb as it has done for the interaction of Mtb with host cell
death (Keane et al., 2000; Velmurugan et al., 2007) and for host
cell autophagy (Shin et al., 2010; Zullo and Lee, 2012). The
long co-evolution of Mtb with humans and the selective pres-
sure applied to human host defense to recognize and react to Mtb
infections leads to the induction of innate immune responses.
Nevertheless, Mtb, having been exposed to these responses, has
adapted to counteract them, which is not the case for NTM.
Consequently, comparing host responses quantitatively between
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virulent Mtb and NTM may offer clues to other Mtb-specific
inhibitory mechanisms.
BACTERIAL MEDIATORS OF INFLAMMASOME INHIBITION
The inhibition of host cell inflammasome response as an immune
evasion strategy has been described for viruses and bacterial
pathogens (Taxman et al., 2010; Lamkanfi and Dixit, 2011; Vande
Walle and Lamkanfi, 2011; Higa et al., 2013). The Pseudomonas
aeruginosa secreted effectors ExoU and ExoS both mediate sup-
pression of NLRC4-inflammasome dependent IL-1β production
via unknown mechanisms (Sutterwala et al., 2007; Galle et al.,
2008). The Yersinia enterocolitica proteins YopE and YopT both
inhibit caspase-1 activation by targeting host cell Rac1 protein
(Schotte et al., 2004). The Y. pseudotuberculosis YopK proteins
bind to components of the bacterial type III secretion system
to inhibit their recognition by host cell inflammasome (Brodsky
et al., 2010). Legionella interferes with inflammasome activa-
tion by inhibiting transcription of the important inflammasome
adapter gene ASC (Abdelaziz et al., 2011).
The Zn-metalloprotease, ZMP1, of Mtb has been implicated
in inhibiting activation of the NLRP3-inflammasome (Master
et al., 2008). Nevertheless, an independently generated zmp1
Mtb deletion mutant failed to reproduce this phenotype (Wong
and Jacobs, 2011). One reason for this difference may be that
most experiments in the study by Master et al. were performed
using a zmp1 mutant in the background of the vaccine strain
M. bovis BCG which lacks functional ESX-1 system. Another
difference between the studies was the type of host cell being
murine cells vs. human THP-1 cell line. The Mtb Rv3364c pro-
tein can bind to and inhibit host cell protease, cathepsin G
(Danelishvili et al., 2011). This inhibition leads to a reduction
in caspase-1 activity and pyroptosis of host cells (Danelishvili
et al., 2011). The impact of the inhibition of caspase-1 on IL-
1β production has not been addressed in that study. Cathepsin
G has also been implicated in inflammasome independent pro-
cessing of pro-IL-1β to mature IL-1β (Hazuda et al., 1990).
Hence there are two potential pathways for the Rv3364c pro-
teins to limit IL-1β production after Mtb infection. Our recent
results suggest that an ESX-1-dependent secreted effector of Mtb
is mediating the inhibition of host cell AIM2-inflammasome
(Shah et al., 2013). In addition, other Mtb proteins may limit
the NLRP3-inflammasome activation via inhibition of IFN-β sig-
naling (Rathinam et al., 2012). In conclusion, there is a growing
list of important human bacterial pathogens that have developed
strategies to manipulate the host cell inflammasome, hence lend-
ing indirectly support to the argument that IL-1β production is
important to host defense. The molecular mechanisms and espe-
cially the bacterial effectors involved in Mtb’s interaction with
host cell inflammasome are poorly defined and merit further
investigations.
CONCLUSIONS
The importance of IL-1β for host immune defense against Mtb
infections is established (Mayer-Barber et al., 2010; Mcelvania
Tekippe et al., 2010; Mayer-Barber et al., 2011). It is also clear
that in vivo IL-1β levels are not affected by the absence of
NLRP3 or ASC during Mtb infections, which highlights the
importance of inflammasome-independent pathways (Mayer-
Barber et al., 2010; Mcelvania Tekippe et al., 2010; Walter et al.,
2010). Consistently, Nlrp3−/− mice are not more susceptible and
Asc−/− mice are only slightly more susceptible to Mtb infec-
tions (Mayer-Barber et al., 2010; Mcelvania Tekippe et al., 2010;
Dorhoi et al., 2012). Here we discussed recent reports demon-
strating that Mtb can inhibit NLRP3-inflammasome activity via
an IFN-β pathway and also either directly or indirectly inhibits
the AIM2-inflammasome. In the light of these findings it is com-
pelling to hypothesize that Mtb may actually be proficient at
inhibiting other types of inflammasomes. Following this line of
thought it may be that the Nlrp3−/− and Asc−/− mice have none
to only minor phenotypes respectively, because Mtb is already
so efficient at inhibiting their activity that even completely tak-
ing away these components of the host defense does not make
much of a difference. Instead, host immune defense has evolved
to develop inflammasome-independent pathways for IL-1β pro-
duction to combat the highly adapted human pathogen Mtb.
Serine proteases such as proteinase-3, elastase and cathepsin-G of
neutrophils have been described to mature pro-IL-1β indepen-
dently of inflammasome activation (Netea et al., 2010). It will
be interesting to investigate if any of the two major cell popu-
lations responsible for IL-1β production in the lungs during Mtb
infection use this mechanism to mature pro-IL-1β (Mayer-Barber
et al., 2011).
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